Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Breathing device tested to reopen collapsed lungs after heart surgery

NCT ID NCT02262182

Symptom relief Sponsor: Nantes University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 14, 2026 · Last updated Sep 15, 2026 · Updated 1 time

Summary

After heart surgery, part of a lung can collapse, a common problem called atelectasis. Researchers are testing whether adding a breathing device called EzPAP, which provides positive pressure on exhale, to standard manual chest physiotherapy helps clear this collapse better than physiotherapy alone. The trial enrolls 80 adults who develop atelectasis after scheduled heart surgery with cardiopulmonary bypass. Half receive EzPAP sessions twice a day plus chest physiotherapy, and half receive chest physiotherapy only. Researchers compare chest X-ray scores after two days and track oxygen levels, breathing, heart rate, pain, and length of intensive care and hospital stay.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
EzPAP positive expiratory pressure device added to manual chest physiotherapy
What this could lead to
If it works, adding EzPAP to standard chest physiotherapy could help patients clear collapsed lung areas faster after heart surgery and possibly shorten intensive care and hospital stays.
What could go wrong
This is a small, single-center trial with 80 patients, so results may not apply broadly. The device could add little benefit over chest physiotherapy alone, and some patients may find the breathing sessions uncomfortable or tiring.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

80 people

The number who actually took part.

Start date

Nov 2014

Finished

Sep 2016

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients admitted in ICU after cardiac surgery by sternotomy with cardiopulmonary bypass presenting a pulmonary atelectasis after extubation, diagnosed by chest X-ray in postoperative period (day1 to day 2). * Patients over 18 years of age * Informed patient Exclusion Criteria: * Cardiac arrhythmia * Hemodynamic instability (mean blood pressure \< 65 mmHg or \> 95 mmHg) * Respiratory rate \> 35/min * Undrained pneumothorax * Predictable trachea intubation or emergent surgery * Patient oral refusal

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pulmonary atelectasis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

middle lobe syndrome Pulmonary Atelectasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pulmonary atelectasis

Contacts and locations

Locations

  • Nantes Universitary Hospital

    Saint-Herblain, 44805, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.